Video
Plasmid DNA: Integrated Solutions for Cell and Gene Therapies
Summary: Plasmid DNA is a critical raw material for cell and gene therapies. Discover the importance of having an integrated partner like Catalent Cell & Gene, and how we can keep your development and manufacturing on track and on schedule.
View Now
Webinars
How Lessons Learned from COVID-19 Pandemic Will Improve Vaccine Development in the Future
Summary: This webinar offers tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs.
View Now
Article
Transitioning from Vial to Prefilled Syringe: How Formulation Development Affects Manufacturing
Summary: Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS).
View Now
Offering Fact Sheet
Drug Substance Manufacturing Infocard
Summary: Catalent Biologics’ drug substance biomanufacturing services provide flexibility and scale to support your growth from clinical to commercial, with options to utilize single-use or stainless-steel bioreactors in a rigorous CGMP environment.
View Now
Offering Fact Sheet
Plasmid DNA Manufacturing
Summary: The Catalent team has broad expertise in developing customized plasmid DNA manufacturing solutions, from plasmid engineering to large-scale GMP plasmid production.
View Now
Podcast
Manufacturing Cell Therapies with an Individualized Mindset
Summary: This podcast focuses on the specialized needs of manufacturing cell therapies at scale and how Custom Manufacturing Organizations are stepping in to drive process efficiencies and standardization.
View Now
Webinars
Introducing GPEx® Lightning: Next Gen Cell Line Engineering to Speed Your Path to Clinic
Summary: During this talk, we share the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx suite of technologies can be tailored to the specific needs of each individual program on its path to clinical trials.
View Now
Article
Overcoming the Raw Material Hurdle: Plasmids for Viral Vector-Based Gene Therapies
Summary: Learn how Catalent Cell & Gene Therapy recognizes the challenges faced when obtaining raw materials, and how our investments in pDNA manufacturing secure our integrated supply chain.
View Now
Executive Summary
Readiness through Planning and Alignment: Guiding Gene Therapies from Clinic to Market
Summary: Learn how integrated service providers can streamline manufacturing, development and commercialization for optimal regulatory and process outcomes for gene therapy programs.
View Now
Executive Summary
Are Real-Time Gene Therapy Test Results Possible?
Summary: Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, in real-time.
View Now